Laurak 250 mg
Laurak 250 mg is a medicine authorised by Swissmedic under authorisation number 69242. The authorisation holder is Neuraxpharm Switzerland AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 October 2024 and the authorisation is limited until 16 October 2029. ATC code N03AX14 places the medicine in the group Antiepileptics.
| Authorisation number | 69242 |
|---|---|
| Name | Laurak 250 mg |
| Full name | Laurak 250 mg, Granulat zur Herstellung einer Lösung zum Einnehmen |
| Authorisation holder | Neuraxpharm Switzerland AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX14 |
| First authorisation | 17 October 2024 |
| Authorisation validity | 16 October 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Laurak 250 mg, Granulat zur Herstellung einer Lösung zum Einnehmen | B | 17 October 2024 |
| 2 | Laurak 500 mg, Granulat zur Herstellung einer Lösung zum Einnehmen | B | 17 October 2024 |
| 3 | Laurak 750 mg, Granulat zur Herstellung einer Lösung zum Einnehmen | B | 17 October 2024 |
| 4 | Laurak 1000 mg, Granulat zur Herstellung einer Lösung zum Einnehmen | B | 17 October 2024 |
| 5 | Laurak 1500 mg, Granulat zur Herstellung einer Lösung zum Einnehmen | B | 17 October 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Beutel | N03AX14 | 01.07.1. | B |
| 2 | 90 | Beutel | N03AX14 | 01.07.1. | B |
| 3 | 180 | Beutel | N03AX14 | 01.07.1. | B |
| 4 | 2x90 | Beutel | N03AX14 | 01.07.1. | B |
| 5 | 30 | Beutel | N03AX14 | 01.07.1. | B |
| 6 | 90 | Beutel | N03AX14 | 01.07.1. | B |
| 7 | 180 | Beutel | N03AX14 | 01.07.1. | B |
| 8 | 2x90 | Beutel | N03AX14 | 01.07.1. | B |
| 21 | 20 | Beutel | N03AX14 | 01.07.1. | B |
| 9 | 30 | Beutel | N03AX14 | 01.07.1. | B |
| 10 | 90 | Beutel | N03AX14 | 01.07.1. | B |
| 11 | 180 | Beutel | N03AX14 | 01.07.1. | B |
| 12 | 2x90 | Beutel | N03AX14 | 01.07.1. | B |
| 13 | 30 | Beutel | N03AX14 | 01.07.1. | B |
| 14 | 90 | Beutel | N03AX14 | 01.07.1. | B |
| 15 | 180 | Beutel | N03AX14 | 01.07.1. | B |
| 16 | 2x90 | Beutel | N03AX14 | 01.07.1. | B |
| 17 | 30 | Beutel | N03AX14 | 01.07.1. | B |
| 18 | 90 | Beutel | N03AX14 | 01.07.1. | B |
| 19 | 180 | Beutel | N03AX14 | 01.07.1. | B |
| 20 | 2x90 | Beutel | N03AX14 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Laurak 250 mg authorised in Switzerland?
Yes. Laurak 250 mg is authorised by Swissmedic under authorisation number 69242, data as of 01 September 2026. The authorisation is limited until 16 October 2029.
Which dispensing category does Laurak 250 mg have?
Laurak 250 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Laurak 250 mg?
The authorisation holder is Neuraxpharm Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.